Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
posted on
Sep 25, 2024 02:33PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
"I will sell my 100k + shares for a buck Canadian. If anyone wants them PM me & we will get it done."
fuzzy: Put them up on the OTC for 10 cents US per share and see what happens.
Koo